Core Viewpoint - The first "2025 China Medical Polymer Materials High-Quality Development Seminar" emphasizes the dual challenges and opportunities in the medical polymer materials industry, advocating for independent innovation and overcoming core technology bottlenecks during the 14th Five-Year Plan period [1][2]. Group 1: Industry Challenges and Opportunities - The petrochemical industry faces urgent needs for structural optimization and supply upgrades, with a notable shortfall in high-end supply compared to mid-low-end supply [2]. - Medical polymer materials are identified as a significant shortcoming in the chemical new materials sector, necessitating increased support and innovation to transition from "catching up" to "leading" in the industry [2]. - The per capita consumption of medical polymer materials in China is significantly lower than that of developed countries, indicating substantial growth potential [2][3]. Group 2: Strategic Initiatives and Developments - The seminar aims to diagnose the industry's shortcomings and create an efficient transformation loop from strategic diagnosis to project implementation, promoting high-quality development in the medical polymer materials sector [1]. - The local government in Tancheng County is leveraging its fine chemical industry cluster and polymer new materials park to accelerate the development of the medical device and medical polymer materials industries [2]. - The introduction of procurement policies, such as "collective procurement," is significantly lowering the prices of medical devices, creating unprecedented market opportunities for domestic materials to replace imports [2]. Group 3: Future Trends and Innovations - The global trend towards stricter regulations on ethylene oxide sterilization emissions presents a strategic opportunity for China to innovate in radiation-resistant medical polymer materials [3]. - The expansion of polyolefin usage, the localization of medical engineering plastics, and the market opportunities for biodegradable polymers are identified as growth drivers for the industry [3].

Core Viewpoint - The research activity in the field of biomedical materials in China has been declining from 2014 to 2024, with a decrease in the number of related papers published from 258 to 152 [3]. Group 1: Definition and Overview - Biomedical materials are defined as high-tech materials used for diagnosing, treating, repairing, or replacing human tissues and organs, categorized by their applications such as bone, soft tissue, cardiovascular, and medical membrane materials [1]. Group 2: Research Trends - The number of papers published in the biomedical materials field has shown a downward trend, indicating a decrease in research interest over the years [3]. - As of July 2025, higher education institutions are the primary contributors to the literature in this field, with Tianjin University leading by publishing 102 related papers [5]. Group 3: Research Themes - Medical polymer materials are identified as a popular research theme within the biomedical materials sector, alongside composite materials [9]. - Biomedical engineering is recognized as a prominent research discipline in this field, with significant contributions from organic chemistry, metallurgy, and metal processing [11].